US stock futures were trending slightly lower in Thursday's premarket activity ahead of a slew of economic data coming out this morning, including Q1 GDP growth, weekly jobless claims, and durable goods orders for May.
The Dow Jones Industrial Average futures were down 0.2%, S&P 500 futures were off 0.1%, and Nasdaq futures were moving 0.2% lower.
Oil prices were moving higher, with front-month global benchmarks Brent crude and West Texas Intermediate crude rising 0.6% and 0.7% respectively.
The Bureau of Economic Analysis' third estimate for Q1 GDP is expected to remain unchanged from its previous estimate with an annual growth rate of 1.3%, according to Investing.com.
Weekly initial jobless claims are expected to decline to 236,000 from 238,00 the previous week, according to Investing.com. US durable goods orders are expected to decline 0.5% in May after increasing 0.7% in April.
In equities, shares of Assure (IONM) soared more than 200% in Thursday's premarket activity, after gaining 2.6% the previous session. CASI Pharmaceuticals' (CASI) shares jumped 43% after the company said late Tuesday that it will submit an investigational new drug application to the US Food and Drug Administration by the end of the year for CID-103 to treat antibody-mediated rejection in kidney transplant patients. Shares of Vigil Neuroscience (VIGL) advanced 32% after the company said Thursday that Sanofi (SNY) has made a $40 million strategic investment in the company at an as-converted price of $7.44 per share of common stock.
On the losing side, shares of BranchOut Food (BOF) plunged 39% after the company said Wednesday it priced an underwritten public offering of about 1.8 million shares of common stock at $0.80 each. Tonix Pharmaceuticals' (TNXP) shares shed almost 32%, after the company said late Tuesday that it plans to offer and sell shares of its common stock or pre-funded warrants. Shares of Bluejay Diagnostics (BJDX) tumbled 26%, adding to Wednesday's nearly 41% loss.
Comments